Venture Partners Llp Advent serves as Executive at Conatus Pharmaceuticals Inc, where they oversee executive responsibilities. Since joining the company, Venture Partners Llp Advent has executed 5 insider transactions totaling $2.1M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 30, 2013 involved selling 535 shares valued at $5.9K.
Venture Partners Llp Advent currently holds 1,957,559 shares of Conatus Pharmaceuticals Inc (CNAT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Venture Partners Llp Advent has been a net buyer of CNAT stock. They have purchased $2.1M and sold $5.9K worth of shares.
Venture Partners Llp Advent's most recent insider trade was on Jul 30, 2013, when they sold 535 shares at $11.00 per share.
Get notified when new Form 4 filings are submitted
| $11.00 |
| Discretionary |
| Jul 30, 2013 | CNAT | $2.1M | Purchase | 190,054 | $11.00 | Discretionary |
| Jul 30, 2013 | CNAT | $5.6K | Exercise | 70,003 | $0.08 | Discretionary |
| Jul 30, 2013 | CNAT | $0 | Conversion | 1,888,091 | $N/A | Discretionary |